Aims Previous trials that investigated cell therapy as an adjunctive therapy after acute
myocardial infarction (AMI) have shown conflicting results. We designed a randomized …

BACKGROUND: Recently, several preliminary reports have demonstrated that cell
transplantation after acute myocardial infarction in humans is safe and leads to better …

Background Previous studies have shown improvement in left ventricular function after
intracoronary injection of autologous cells derived from bone marrow (BMC) in the acute …

Aims Intracoronary administration of autologous bone marrow cells (BMCs) leads to a
modest improvement in cardiac function, but the effect on myocardial viability is unknown …

Objective: To investigate long-term safety and efficacy after intracoronary injection of
autologous mononuclear bone marrow cells (mBMCs) in acute myocardial infarction (AMI) …

Abstract Background In the REPAIR-AMI trial, intracoronary infusion of bone marrow-derived
cells (BMCs) was associated with a significantly greater recovery of contractile function in …

To the Editor: One-third of patients with ST-segment elevation myocardial infarction, usually
those presenting late, show ongoing left ventricular (LV) remodeling and poor clinical …

Context Clinical trial results suggest that intracoronary delivery of autologous bone marrow
mononuclear cells (BMCs) may improve left ventricular (LV) function when administered …

Aims We sought to determine whether repeat administration of bone marrow mononuclear
cells (BMC) can improve left ventricular function compared with a single infusion in patients …

To assess the effect of autologous bone-marrow cell (BMC) therapy in patients with acute
myocardial infarction in a rigorous double-blind, randomized, placebo-controlled trial …